START Midwest - Cancer & Hematology Centers of Western Michigan — Grand Rapids, Michigan

START Midwest - Cancer & Hematology Centers of Western Michigan is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

START Midwest - Cancer & Hematology Centers of Western Michigan has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Cancer, RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors.

Sponsors: Jounce Therapeutics, Inc., Taiho Pharmaceutical Co., Ltd..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Midwest - Cancer & Hematology Centers of Western Michigan?

START Midwest - Cancer & Hematology Centers of Western Michigan has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Midwest - Cancer & Hematology Centers of Western Michigan conducted?

START Midwest - Cancer & Hematology Centers of Western Michigan has 2 clinical trials on record, with 1 currently active. Their work covers Cancer, RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors.

Is START Midwest - Cancer & Hematology Centers of Western Michigan accredited by Crixeo Health?

START Midwest - Cancer & Hematology Centers of Western Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Midwest - Cancer & Hematology Centers of Western Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.